Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xiangya Hospital Of Central South University

Clinical trials sponsored by Xiangya Hospital Of Central South University, explained in plain language.

Trials to join now! 3 Not yet recruiting 9 Not yet finished but already full! 1 Completed 4

New combo attack on tough liver cancer

Disease control ENROLLING_BY_INVITATION

This early-stage study is testing the safety of a three-part treatment for liver cancer that cannot be removed by surgery. The treatment combines two immunotherapy drugs (JS014 and Toripalimab) with a standard procedure that blocks the tumor's blood supply (TACE). The goal is to …

Phase: PHASE1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC